Difference between revisions of "MEDICATION-LIGNOCAINE"

From NeuroRehab.wiki

(Imported from text file)
 
(Imported from text file)
 
(8 intermediate revisions by 2 users not shown)
Line 1: Line 1:
1. Acts as a membrane stabilising agent, used for its anti-arrhythmic effects.<div>2. Indications: VF/pulseless or VT refractory to defibrillation.</div><div><br></div><div>SE</div><div>3. Nausea & vomiting.</div><div>4. CNS: slurred speech, drowsiness, seizures.</div><div>5. CVS: bradycardia, heart block, asystole. </div><div><br></div><div>DOSAGE</div><div>6. Initially 1 mg/kg bolus after the third DC shock, additional bolus of 0.5 mg/kg (up to 200 mg) may be considered.  </div>
===== [[Summary Article|'''SUMMARY''']] =====
 
1. Acts as a membrane stabilising agent, used for its anti-arrhythmic effects.
<br/>2. Indications: VF/pulseless or VT refractory to defibrillation.
<br/>
<br/>SE
<br/>3. Nausea &amp; vomiting.
<br/>
<br/>4. CNS: slurred speech, drowsiness, seizures.
<br/>5. CVS: bradycardia, heart block, asystole.  
<br/>
<br/>DOSAGE
<br/>6. Initially 1 mg/kg bolus after the third DC shock, additional bolus of 0.5 mg/kg (up to 200 mg) may be considered.   


[[Category:Medication]]
[[Category:Medication]]
[[Category:Advanced Life Support]]

Latest revision as of 11:31, 1 January 2023

SUMMARY

1. Acts as a membrane stabilising agent, used for its anti-arrhythmic effects.
2. Indications: VF/pulseless or VT refractory to defibrillation.

SE
3. Nausea & vomiting.

4. CNS: slurred speech, drowsiness, seizures.
5. CVS: bradycardia, heart block, asystole.

DOSAGE
6. Initially 1 mg/kg bolus after the third DC shock, additional bolus of 0.5 mg/kg (up to 200 mg) may be considered.